2 insiders bought €2.6M of shares over the last 90 days, the latest filed 16 Oct 2026.
Cluster: 2 buyers in 30 daysInstituto de Diagnostico S.A. is a listed company. Its directors and officers file their transactions with CMF (Chile). 3 insiders have disclosed 4 filings since 18 October 2025.
On the market, 2 insiders bought (3 purchases totalling €2.6M) while 1 insider sold (1 sale totalling €70k). Purchases outweigh sales by €2.6M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. At €1.6M, the purchase published on 2 October 2026 by Instituto de Diagnostico S.A. is the largest of the period. Among those who bought: 2 major shareholders and 1 chief executive.
For context, the typical company on the same exchange (median of 32 companies) published 3 filings over the same period, against 4 filings here. Our records for Instituto de Diagnostico S.A. go back to 2026, with 3 purchases and 1 sale on the open market in total.
The latest purchase is recent: it was published 2 days ago, on 16 October 2026. The median gap between a trade and its publication by CMF (Chile) is 1 day. That lag is the time during which only the insider knows about the trade.
Source: insider filings from CMF (Chile). Past trades are no guide to future returns.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
Instituto de Diagnostico S.A. is a company specializing in medical diagnostic services. It operates in the XSGO market.
Insider filings
Over the last 90 days, 4 filings published between 2 October and 16 October 2026: 1 open-market purchase by insiders for €35k, 1 sale for €70k. The company also filed 2 transactions in its own shares (buybacks or cancellations) for €2.6M; these are not insider purchases. Largest amounts: ISLA DE VIS LIMITADA (Controlador), sales of €70k; INVERSIONES LA CALETA S.A. (Controlador), purchases of €35k.
Summary written automatically from public filings, without human review. General information, identical for every reader: it is not investment advice or a recommendation to buy or sell. Investing involves a risk of capital loss. Generated on 17 October 2026 (UTC)